Willingness to Discuss Clinical Trials Among Black vs White Men With Prostate Cancer.

ABSTRACT:

Importance

Black individuals are underrepresented in cancer clinical trials.

Objective

To examine whether Black and White men with prostate cancer differ in their willingness to discuss clinical trials with their physicians and, if so, whether patient-level barriers statistically mediate racial differences.

Design, setting, and participants

This cross-sectional survey study used baseline data from Partnering Around Cancer Clinical Trials, a randomized clinical trial to increase Black individuals' enrollment in prostate cancer clinical trials. Data were collected from 2016 through 2019 at 2 National Cancer Institute-designated comprehensive cancer centers; participants were Black and White men with intermediate-risk to high-risk prostate cancer. In mediation analysis,

SUBMITTER: Senft N 

PROVIDER: S-EPMC7499244 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature